Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 5/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 0.90 |
| ▸ | TSHR | P16473 | 1/20 | 0.90 |
| ▸ | PLA2G4B | P0C869 | 8/20 | 0.88 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.78 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.71 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2354189 | 1.00 | RARB (1.00) | RARBTP53TSHRPLA2G4BPLA2G4A | |
| SCHEMBL7172427 | 1.00 | RARB (1.00) | RARBTP53TSHRPLA2G4BPLA2G4A | |
| SCHEMBL8535621 | 1.00 | RARB (1.00) | RARBTP53TSHRPLA2G4BPLA2G4A | |
| SCHEMBL8300827 | 1.00 | RARB (1.00) | RARBTP53TSHRPLA2G4BPLA2G4A | |
| SCHEMBL8943017 | 1.00 | RARB (1.00) | RARBTP53TSHRPLA2G4BPLA2G4A | |
| SCHEMBL8532269 | 1.00 | RARB (1.00) | RARBTP53TSHRPLA2G4BPLA2G4A | |
| SCHEMBL641904 | 1.00 | RARB (1.00) | RARBTP53TSHRPLA2G4BPLA2G4A | |
| SCHEMBL4185457 | 1.00 | RARB (1.00) | RARBTP53TSHRPLA2G4BPLA2G4A | |
| SCHEMBL5858775 | 1.00 | RARB (1.00) | RARBTP53TSHRPLA2G4BPLA2G4A | |
| SCHEMBL2038307 | 1.00 | RARB (1.00) | RARBTP53TSHRPLA2G4BPLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7022259-B2 | Liquid crystal compounds, preparation thereof, and composition containing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2006-04-04 | — | — | US | claimed |
| US-20050189515-A1 | Liquid crystal compounds, preparation thereof, and composition containing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2005-09-01 | — | — | US | claimed |
| EP-0327349-B1 | Liquid crystal compounds | SHOWA SHELL SEKIYU (JP) | 1996-04-10 | — | — | EP | claimed |
| US-4921632-A | Liquid crystal compounds and compositions | NEC CORPORATION (JP) | 1990-05-01 | — | — | US | claimed |
| JP-11310550-A | — | — | None | — | — | JP | disclosed |
| JP-8245672-A | — | — | None | — | — | JP | disclosed |
| JP-5201929-A | — | — | None | — | — | JP | disclosed |
| JP-4282345-A | — | — | None | — | — | JP | disclosed |
| JP-4282344-A | — | — | None | — | — | JP | disclosed |
| US-20250388766-A1 | METAL OXIDE DISPERSON AND METHOD FOR MANUFACTURING METAL OXIDE FILM USING SAME | TOKYO OHKA KOGYO CO LTD (JP) | 2025-12-25 | — | — | US | disclosed |
| WO-2023248996-A1 | METAL OXIDE DISPERSON AND METHOD FOR MANUFACTURING METAL OXIDE FILM USING SAME | 東京応化工業株式会社 | 2023-12-28 | — | — | WO | disclosed |
| US-20220296579-A1 | COMPOSITIONS AND METHODS FOR PROVIDING CARDIOPROTECTIVE EFFECTS | CORNELL UNIVERSITY (US) | 2022-09-22 | — | — | US | disclosed |
| EP-0255962-A2 | Optically active mesomorphic compound | CANON KABUSHIKI KAISHA (JP) | 1988-02-17 | — | — | EP | disclosed |
| EP-0240184-A2 | Alpha-Methylcinnamic acid ester derivative and liquid crystal composition | MITSUBISHI RAYON CO., LTD. (JP) | 1987-10-07 | — | — | EP | disclosed |
| EP-0211030-A1 | Ferro-electric smectic liquid crystal materials based on terpenoid derivatives. | SECR DEFENCE BRIT (GB) | 1987-02-25 | — | — | EP | disclosed |
| EP-0201554-A1 | COMPOUNDS FOR FERROELECTRIC LIQUID CRYSTAL DEVICES. | SECR DEFENCE BRIT (GB) | 1986-11-20 | — | — | EP | disclosed |
| EP-0197677-A2 | Halogen-containing, optically active liquid crystal compound and liquid crystal composition containing same | Chisso Corporation (JP) | 1986-10-15 | — | — | EP | disclosed |
| WO-1986004328-A1 | TERPENOID DERIVATIVES AND LIQUID CRYSTAL MATERIALS AND DEVICES CONTAINING THEM | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNI (GB) | 1986-07-31 | — | — | WO | disclosed |
| EP-0188222-A2 | Novel liquid cristalline compounds having substituents | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1986-07-23 | — | — | EP | disclosed |
| WO-1986002937-A1 | COMPOUNDS FOR FERROELECTRIC LIQUID CRYSTAL DEVICES | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNI (GB) | 1986-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220296579-A1 | COMPOSITIONS AND METHODS FOR PROVIDING CARDIOPROTECTIVE EFFECTS | RARB, RARG, RARA | RARB 1/4885TP53 3965/4885TSHR 594/4885 |
| US-20250388766-A1 | METAL OXIDE DISPERSON AND METHOD FOR MANUFACTURING METAL OXIDE FILM USING SAME | TPR, TMCO1, CD63 | RARB 1245/4885TP53 130/4885TSHR 1840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.